FDA rejects Venatorx Pharmaceuticals' new drug application for flagship product

Founded in 2010, Venatorx Pharmaceuticals is backed by more than $120 million in financing.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 23, 2024 Category: Pharmaceuticals Authors: John George Source Type: news